| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancing equitable and personalized cancer care: Novel applications and priorities of artificial intelligence for fairness and inclusivity in the patient care workflow
|
Cobanaj, Marisa
|
|
|
198 |
C |
p.
|
artikel
|
| 2 |
Cancer screenings in Poland. A call to the new government and health minister for informed leadership
|
Koczkodaj, Paweł
|
|
|
198 |
C |
p.
|
artikel
|
| 3 |
C-C chemokine receptor 4 (CCR4)-positive regulatory T cells interact with tumor-associated macrophages to facilitate metastatic potential after radiation
|
Chiang, Yun
|
|
|
198 |
C |
p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
198 |
C |
p.
|
artikel
|
| 5 |
Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma – An analysis of the prospective skin cancer registry ADOREG
|
Kochanek, Corinna
|
|
|
198 |
C |
p.
|
artikel
|
| 6 |
Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer
|
Fasching, Peter A.
|
|
|
198 |
C |
p.
|
artikel
|
| 7 |
EUSOMA quality indicators for non-metastatic breast cancer: An update
|
Rubio, Isabel T.
|
|
|
198 |
C |
p.
|
artikel
|
| 8 |
Every tenth malignant solid tumor attributed to overweight and alcohol consumption: A population-based cohort study
|
Seppä, Karri
|
|
|
198 |
C |
p.
|
artikel
|
| 9 |
Immunotherapy in mismatch repair-deficient metastatic colorectal cancer – Outcome and novel predictive markers
|
Stemmer, Amos
|
|
|
198 |
C |
p.
|
artikel
|
| 10 |
Letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study
|
Lu, Wentian
|
|
|
198 |
C |
p.
|
artikel
|
| 11 |
METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors
|
André, Nicolas
|
|
|
198 |
C |
p.
|
artikel
|
| 12 |
Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies
|
Shahnam, Adel
|
|
|
198 |
C |
p.
|
artikel
|
| 13 |
PD-L1 is a biomarker of real-world clinical outcomes for anti-CTLA-4 plus anti-PD-1 or anti-PD-1 monotherapy in metastatic melanoma
|
Ellebaek, Eva
|
|
|
198 |
C |
p.
|
artikel
|
| 14 |
Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study
|
Ben Khaled, Najib
|
|
|
198 |
C |
p.
|
artikel
|
| 15 |
Risk factors for early-onset pancreatic ductal adenocarcinoma: A systematic literature review
|
Chandana, Sreenivasa R.
|
|
|
198 |
C |
p.
|
artikel
|
| 16 |
Seasonal patterns of toxicity in melanoma patients treated with combination anti-PD-1 and anti-CTLA-4 immunotherapy
|
Rogiers, Aljosja
|
|
|
198 |
C |
p.
|
artikel
|
| 17 |
The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role?
|
Di Giacomo, Anna Maria
|
|
|
198 |
C |
p.
|
artikel
|
| 18 |
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial
|
Le Rhun, Emilie
|
|
|
198 |
C |
p.
|
artikel
|
Tijdschrift beschrijving